Ambros Therapeutics’ Path for Pain Drug Goes Through Reverse Merger With WerewolfNews DeskAugust 21, 20260 Some types of pain don’t respond to currently available medicines. Ambros Therapeutics’ in-licensed drug candidate is in pivotal testing for…
Slate Medicines’ Merger and $245M Private Placement Fuel Mission in MigraineNews DeskAugust 17, 20260 When Slate Medicines launched early this year backed by a mega-round of financing, the company claimed best-in-class potential for its…